Page last updated: 2024-09-03

n,n-dimethylarginine and Hepatic Failure

n,n-dimethylarginine has been researched along with Hepatic Failure in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kuik, DJ; Nijveldt, RJ; Rauwerda, JA; Siroen, MP; Teerlink, T; Van Der Hoven, B; van Leeuwen, PA1
Kuik, DJ; Kuipers, EJ; Meijer, S; Metselaar, HJ; Nijveldt, RJ; Siroen, MP; Teerlink, T; Tilanus, HW; van der Hoven, B; van der Sijp, JR; van Leeuwen, PA; Warlé, MC1

Other Studies

2 other study(ies) available for n,n-dimethylarginine and Hepatic Failure

ArticleYear
Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality.
    Clinical nutrition (Edinburgh, Scotland), 2003, Volume: 22, Issue:1

    Topics: Adult; Aged; Analysis of Variance; Arginine; Critical Illness; Cross-Sectional Studies; Enzyme Inhibitors; Female; Humans; Intensive Care Units; Liver Failure; Male; Middle Aged; Multiple Organ Failure; Pilot Projects; Renal Insufficiency; Risk Factors

2003
The transplanted liver graft is capable of clearing asymmetric dimethylarginine.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2004, Volume: 10, Issue:12

    Topics: Acute Disease; Arginine; Biomarkers; Case-Control Studies; Chronic Disease; Graft Rejection; Humans; Kidney; Liver; Liver Failure; Liver Transplantation; Osmolar Concentration; Postoperative Period; Prospective Studies

2004